Analyst Ratings For Clinigen Group PLC (LON:CLIN)
Today, Clinigen Group PLC (LON:CLIN) stock was downgraded by Numis Securities Ltd from Add to with a price target of GBX 1,100.
There are 1 hold rating, 3 buy ratings on the stock.
The current consensus rating on Clinigen Group PLC (LON:CLIN) is Buy (Score: 2.75) with a consensus target price of GBX 1,041.25 per share, a potential .
Some recent analyst ratings include
- 7/18/2017-Numis Securities Ltd was Downgraded by analysts at Numis Securities Ltd from a “Add” rating to a “” rating. They now have a GBX 1,100 price target on the stock.
- 5/22/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 4/13/2017-N+1 Singer Reiterated Rating of Buy.
Recent Trading Activity for Clinigen Group PLC (LON:CLIN)
Shares of Clinigen Group PLC closed the previous trading session at 907.97 down -31.53 -3.36% with 113,829 shares trading hands.
